Nicola Valeri

Nicola Valeri has established clinical organoid programs that co-enroll patients in clinical trials with parallel organoid drug sensitivity testing, enabling real-time correlation of in vitro pharmacotyping with patient outcomes. His work demonstrating that organoid drug responses predict clinical benefit in colorectal cancer has advanced the field toward organoid-guided precision oncology. He leads multi-institutional European organoid clinical trial networks.